Advancements in Epilepsy Management: The Role of NeuroPace RNS® System in Neurostimulation

Advancements in Epilepsy Management: The Role of NeuroPace RNS® System in Neurostimulation Author’s Name The Institutional Affiliation Course Number and Name Instructor Name Assignment Due Date Introduction Epilepsy is defined as a chronic neurological disorder characterized by unpredictable and recurrent seizures. Repeated seizures result from an imbalance in the brain’s electrical activity (Rees & Andrews, n.d.). The cyclic rhythm of the brain is disrupted by rapid, uncontrolled bursts of electrical energy, causing momentary alterations to the person’s behavior and perceptions. Globally, around 50 million people have epilepsy, with approximately 20 percent experiencing intractable seizures (American Association of Neurological Surgeons, 2023), emphasizing the urgency of exploring new treatment options. Although antiepileptic medicines are the first line of treatment to control seizures, recent advancements in the management of epilepsy have provided a better approach to addressing the complex interactions within the damaged regions of the brain. One such example is the novel NeuroPace RNS® System, which offers an enhanced treatment option due to its less invasive but highly effective procedure. The following report highlights the application and advantages of the NeuroPace RNS System in the treatment of specific regions of the brain associated with epileptic seizures. The Role of NeuroPace RNS® System in Epilepsy Management Compared to oral medications or surgeries, often involving the extraction of the compromised brain region, the NeuroPace RNS® System was developed to produce enhanced results while minimally invasive. The system produces electrical stimulation, directly focusing on the affected brain region from where the seizures originate. This treatment approach was designed for those patients, in particular, who had stopped responding to conventional medications. This alternative was deemed better due to its superiority in terms of directly targeting the source of seizures and drastically reducing the frequency of epileptic episodes as opposed to traditional methods. Moreover, it provides a ‘glimpse’ into the brain, allowing medical professionals to monitor the abnormal activity and opt for the treatment more suited to their patient. The device identifies the aberrant brainwaves and prevents the seizure from developing by producing precise electrical stimulations (University of Pittsburgh, 2024). This technique is known as ‘responsive neurostimulation.’ The device includes electrodes inserted directly into the brain and a neurostimulator to monitor brain activity and determine seizure patterns. Although it was developed in the early 2000s, the device has undergone multiple changes until it was finally approved by the FDA in 2013 to treat epilepsy. Several clinical trials aided its refinement to augment its safety and efficacy. Thus, it is now considered a prominent tool in treating epilepsy, especially for patients who suffer from drug-resistant seizures. Neurological Compromises Addressed by NeuroPace RNS® System The NeuroPace RNS® System was designed primarily to treat drug-resistant focal epilepsy, which is characterized by frequent seizures that not only arise from a specific lobe of the brain but also do not respond to oral medications (Plummer et al., 2008). Although the seizures are specific to certain regions within the brain, their location and onset may vary from person to person. These specific regions harboring recurrent seizures due to abnormal electrical activity are known as epileptogenic zones (Jehi, 2018). These zones are the cortical areas from which the epileptic seizures are generated. The seizure may also manifest in a distinct region of the brain’s cortex but may move to other areas in close proximity. The mesial temporal lobe is one of the prominent regions in cases of epilepsy. It houses the hippocampus, which is critical in memory and learning functions. The occurrence of abnormalities in the hippocampus may cause the generation of unprovoked seizures (Tatum, 2012). This epilepsy is known as mesial temporal lobe epilepsy. Other epileptogenic zones include the four different lobes of the brain: occipital, frontal, parietal, and temporal (Thijs et al., 2019). These affected regions must be studied separately to customize the therapies when accurately targeting abnormal brain activity at its origin source. Each of the brain’s four lobes is responsible for its unique function. Therefore, the occurrence of seizures within these lobes disrupts the normal functioning of the outcome they control. For example, since the frontal lobe is responsible for movement and emotions, seizures in this region may produce uncontrolled muscle twitching and frequent mood changes, disturbing both the emotional and motor functioning of the patient. Secondly, the temporal lobe, which acts as the control center of all the auditory information, including language, may cause slurred speech and frequent delusional thoughts in patients with epilepsy. Similarly, the seizures in the parietal lobe would potentially give rise to constant dizziness and heating sensations. The fourth occipital lobe may contribute to difficulties in visionary functions when affected. Focal epilepsy mainly occurs when there is an imbalance of the neurons within the brain. The brain contains two different types of neurons: excitable and inhibitory. The excitable neuron carries forward the signal while the inhibitory ones stop the signal transmission (Li et al., 2023). These neurons make up the complete brain’s neurocircuit. A seizure may occur if any aberrant electrical activity is observed within this vast network. Several factors may give birth to this imbalance. The most common reason is the decline in the number of the inhibitory neurons as opposed to their excitable counterparts. Since their loss causes unlimited signal transmission through the excitable ones, a sudden upsurge of signals may occur, leading to a seizure. Another reason includes the disruption of synaptic checkpoints, which causes an abnormal exchange of signals between the neurons. The ion channels may also add to seizure development in case of loss of control over the movement of ions into and out of the neurons. Lastly, the disparity of neurotransmitters may also birth an excess of excitable neurons (Bromfield et al., 2015). All of the abovementioned reasons may lead to the disruption of this complex network, causing seizures to occur at an uncontrolled rate. The NeuroPace RNS® system is critical in controlling the disturbances caused by compromised epileptic regions. The system utilizes its neurostimulation ability to retort abnormal electrical activity, providing effective seizure control in real-time. The device is performed by directly monitoring and targeting the abnormal activity in the hippocampu...